A Clinic-Radiomics Model for Predicting the Incidence of Persistent Organ Failure in Patients with Acute Necrotizing Pancreatitis
Table 1
Clinical characteristics.
Development cohort ()
Validation cohort ()
-value
Age, years
0.629
Median
46
48
Range
17–84
24–79
Gender
0.358
Male
84 (67.2)
40 (75.5)
Female
41 (32.8)
13 (24.5)
BMI, kg/m2
0.583
≥25.0
73 (58.4)
34 (64.2)
<25.0
52 (41.6)
19 (35.8)
ASA grade
0.065
≥III
37 (29.6)
24 (45.3)
<III
88 (70.4)
29 (54.7)
Etiology
0.335
Hyperlipidemia
47 (37.6)
24 (45.3)
Biliary
56 (44.8)
24 (45.3)
Others
22 (17.6)
5 (9.4)
Past history of AP
0.223
Present
34 (27.2)
20 (37.7)
Absent
91 (72.8)
33 (62.3)
APACHE II, points
0.203
57 (45.6)
18 (33.9)
68 (54.4)
35 (66.1)
Persistent SIRS
0.130
Present
76 (60.8)
25 (47.2)
Absent
49 (39.2)
28 (52.8)
Persistent OF
0.407
Present
75 (60.0)
36 (67.9)
Absent
50 (40.0)
17 (32.1)
Intervention
0.721
Present
42 (33.6)
20 (37.7)
Absent
83 (66.4)
33 (62.3)
Infected necrosis
0.656
Present
32 (25.6)
16 (30.2)
Absent
93 (74.4)
37 (69.8)
Mechanical ventilation
0.951
Present
40 (32.0)
16 (30.2)
Absent
85 (68.0)
37 (69.8)
ICU admission
0.347
Present
84 (67.2)
31 (58.5)
Absent
41 (32.8)
22 (41.5)
Hospital stay (over 30 days)
0.721
Present
42 (33.6)
20 (37.7)
Absent
83 (66.4)
33 (62.3)
Mortality
0.815
Present
10 (8.0)
3 (5.7)
Absent
115 (92.0)
50 (94.3)
Data are presented as median with range or number with percentage. BMI, body mass index; ASA, American Society of Anesthesiologists; AP, acute pancreatitis; APACHE, Acute Physiology and Chronic Health Evaluation; SIRS, systemic inflammatory response syndrome; OF, organ failure; ICU, intensive care unit.